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Several studies reported fenretinide (4-HPR) can be used as antitumoral drug in 
many types of cancer cell lines such as neuroblastoma, mammary carcinoma and mel-
anoma. In vitro 4-HPR inhibits growth of neuroblastoma in a dose dependent manner 
with an high antitumor activity at 5–10 μM (Ponzoni et al., 1995).The main disadvan-
tage of 4HPR in clinical application is its lipophilic behavior which hinders the possi-
bility to maintain therapeutic concentration for long period of time.
To bypass this drawback, new drug delivery systems consisting in polylactide 
(PLA) or polylactide-co-glycolid (PLGA) microspheres were developd. A novel sol-
vent extraction method based on the co-precipitation of PLA or PLGA with gelatin 
has been utilized. Phosphatidylcholine (PC) or dextrin (DX) were added to improve 
the hydrophilic character of the microsphere surface.
After a preliminary study of physical characteristics in terms of encapsulation effi-
ciency, mean size and release profile of drug, PLA/gelatin/dextrin MS were chosen 
to test the antitumor activity in SH-SY5Y neuroblastoma cell line.
After 3 and 24 hours of treatment a cell viability of 50 % and 0% was observed 
respectively. Empty MS did not affect the cell viability at the same time points. High 
resolution SEM showed an high bioadhesion of PLA/gelatin/dextrin microspheres to 
cell membrane. Cell uptake experiments demonstrated an high intracellular concen-
trations of fenretinide in the presence of the PLA/gelatin/dextrin microspheres rath-
er than in the presence of pure fenretinide. 
In conclusion, 4-HPR loaded in PLA/gelatin/dextrin microspheres represent 
a powerful tool for drug delivery systems for hydrophobic antitumor drugs whose 
therapeutic potential is hindered by their low availability.
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